Biotech

All Articles

Lundbeck slashes worth of $250M Abide buyout after discomfort drawback

.Lundbeck is slashing the book market value of its own $250 million Abide Therapeutics buyout in fee...

Real- World Data Meets Scientific Trial Concept: Improving Protocols and Website Choice

.The assimilation of real-world data (RWD) into protocol feasibility and also site option has actual...

Where are they today? Overtaking past Brutal 15 honorees

.At this year's Ferocious Biotech Peak in Boston, we overtook leaders in the biotech business who ha...

Merck snaps up preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is setting down $30 thousand ahead of time to buy Yale spinout Modifi Biosciences, a...

Radiopharma Alpha-9 elevates $175M collection C to money medical press

.Alpha-9 Oncology has actually increased a $175 million series C round to stake its clinical-stage r...

Ocuphire to completely transform into gene therapy biotech through Piece buyout

.Eye medication creator Ocuphire Pharma is acquiring genetics therapy developer Piece Genetic makeup...

Roche culls cough prospect, pivots KRAS plan in Q3 update

.Roche's constant cough plan has actually sputtered to a stop. The drugmaker, which axed the system ...

Merck- Gilead long-acting oral combination suppresses HIV for 48 weeks

.Gilead Sciences and also Merck &amp Co. have actually directed their once-weekly HIV combination th...

Lykos takes FDA check out that MDMA authorization counts on fresh trial

.Lykos Therapies may have shed three-quarters of its own staff in the wake of the FDA's rejection of...

Septerna intends $158M IPO to fund readouts for GPCR pipe

.Septerna might be as yet to divulge "any kind of purposeful professional information," yet the biot...